Last reviewed · How we verify

Postop oral oxycodone

AdventHealth · FDA-approved active Small molecule Under review Quality 0/100

Postop oral oxycodone is a Opioid analgesic Small molecule drug developed by AdventHealth. It is currently FDA-approved for Postoperative pain management (acute pain following surgery). Also known as: Roxicodone.

Oxycodone binds to opioid receptors in the central nervous system to block pain signal transmission and provide analgesia.

Postoperative oral oxycodone is used to treat conditions such as pancreatic cancer, surgery complications, pancreatic fistula, delayed gastric emptying, and pancreatic hemorrhage. As a mu opioid receptor agonist, it works by activating the mu-type opioid receptor, which is a small molecule drug that belongs to the agonist class.

At a glance

Generic namePostop oral oxycodone
Also known asRoxicodone
SponsorAdventHealth
Drug classOpioid analgesic
TargetMu (μ) opioid receptor
ModalitySmall molecule
Therapeutic areaPain Management
PhaseFDA-approved

Mechanism of action

Oxycodone is a semi-synthetic opioid agonist that binds primarily to mu (μ) opioid receptors in the brain and spinal cord, reducing the perception and emotional response to pain. In the postoperative setting, it is used for moderate to severe acute pain management following surgery. The drug crosses the blood-brain barrier and modulates pain signaling pathways, providing rapid onset analgesia when administered orally.

Approved indications

Common side effects

Key clinical trials

Primary sources

Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.

SourceUsed for
ClinicalTrials.govTrial enrolment, design, endpoints, results

Competitive intelligence

For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:

Frequently asked questions about Postop oral oxycodone

What is Postop oral oxycodone?

Postop oral oxycodone is a Opioid analgesic drug developed by AdventHealth, indicated for Postoperative pain management (acute pain following surgery).

How does Postop oral oxycodone work?

Oxycodone binds to opioid receptors in the central nervous system to block pain signal transmission and provide analgesia.

What is Postop oral oxycodone used for?

Postop oral oxycodone is indicated for Postoperative pain management (acute pain following surgery).

Who makes Postop oral oxycodone?

Postop oral oxycodone is developed and marketed by AdventHealth (see full AdventHealth pipeline at /company/adventhealth).

Is Postop oral oxycodone also known as anything else?

Postop oral oxycodone is also known as Roxicodone.

What drug class is Postop oral oxycodone in?

Postop oral oxycodone belongs to the Opioid analgesic class. See all Opioid analgesic drugs at /class/opioid-analgesic.

What development phase is Postop oral oxycodone in?

Postop oral oxycodone is FDA-approved (marketed).

What are the side effects of Postop oral oxycodone?

Common side effects of Postop oral oxycodone include Constipation, Nausea, Dizziness, Drowsiness, Vomiting, Pruritus.

What does Postop oral oxycodone target?

Postop oral oxycodone targets Mu (μ) opioid receptor and is a Opioid analgesic.

Related

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing